We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rapid Implementation of Novel Affinity Purification
Whitepaper

Rapid Implementation of Novel Affinity Purification

Rapid Implementation of Novel Affinity Purification
Whitepaper

Rapid Implementation of Novel Affinity Purification

The rapid and cost-effective production of conventional monoclonal antibodies (mAbs) for clinical trials has contributed toward their wide adoption. As the number of next-generation antibody-based candidates with modified or absent Fc domains increases, biomanufacturers face a need to establish alternative affinity purification technologies.

Download this whitepaper to discover affinity resins that:

  • Provide a scalable platform solution for efficient therapeutic antibody purification 
  • Can be used in commercial manufacturing processes of antibody therapeutics
  • Provide increased capacity and high purity of novel antibody formats in a single capture step
Advertisement